CytoDyn Market Cap

CytoDyn has a market cap or net worth of $435.04 million as of June 9, 2025. Its market cap has increased by 82.57% in one year.

Market Cap

435.04M

Enterprise Value

445.96M

Revenue

n/a

Ranking

n/a

PE Ratio

n/a

Stock Price

$0.35

Market Cap Chart

Since November 17, 2005, CytoDyn's market cap has increased from 5.54M to 435.04M, an increase of 7,756.26%. That is a compound annual growth rate of 24.98%.

Market Cap History

Date	Market Cap	% Change
Jun 9, 2025	435.04M	223.13%
Dec 31, 2024	134.63M	-29.42%
Dec 29, 2023	190.74M	2.63%
Dec 30, 2022	185.85M	-72.64%
Dec 31, 2021	679.28M	-78.86%
Dec 31, 2020	3.21B	695.20%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Endo Inc.	1.66B
Veradigm	747.25M
Nika Pharmaceuticals	666.65M
Tian'an Technology Group	637.25M
Elite Pharmaceuticals	619.60M
Glass House Brands	444.40M
Northwest Biotherapeutics	391.87M
American Oncology Network	347.00M

Market Cap Rankings